Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

The Biden administration's Food and Drug Administration (FDA) released additional details on a proposed rule that would ...

Novo Nordisk's financial strength is evident through its 74% historical average ROIC and 85% gross margin. See why I rate NVO ...

A synthetic food dye commonly added to candy and sweets is being pulled from the market. This week, the Food and Drug ...

Eli Lilly ( LLY -6.59%) is the most valuable healthcare stock in the world, with a market capitalization of around $720 ...

The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...